终末期肾病患者循环微生物特征与心血管死亡的关系
这项初步病例对照研究纳入17例死于心血管事件的血液透析患者和17例匹配的存活对照,中位随访2.0年,比较血清中循环微生物组(细菌、古菌、真菌)的水平与组成,发现两组间分类学组成存在差异,放线菌门比例较高且与心血管死亡风险边缘相关。
要点
- ESRD血液透析患者血清中可检测到细菌和真菌rRNA。
- 心血管死亡者放线菌门比例较高、变形菌门较低。
- 放线菌门和变形菌门比例与血浆Nrf2水平相关。
核心结论
- 循环游离微生物特征改变可能与ESRD患者过早心血管死亡风险升高相关。
研究设计与样本
- 初步病例对照研究,纳入17例死于心血管事件的血液透析患者和17例匹配的存活对照,中位随访2.0年。
- 采用定量PCR和16S或ITS rRNA测序比较血清中细菌、古菌和真菌的水平与组成。
- 使用Spearman秩相关和多变量条件logistic回归分析微生物特征与临床参数及心血管死亡的关联。
主要发现
- 所有受检患者血清中均可检测到16S rRNA,除3例外均可检测到ITS rRNA。
- 病例组与对照组间16S rRNA水平和α多样性无显著差异。
- 在门水平上,病例组放线菌门显著多于对照组,变形菌门显著少于对照组。
- 放线菌门和变形菌门比例与血浆Nrf2水平显著相关(rho=-0.41和0.42,P=0.015和0.013)。
- 放线菌门和变形菌门比例与心血管死亡风险边缘相关(每增加1%的调整OR[95%CI]分别为1.12[0.98-1.29]和0.88[0.76-1.02])。
临床怎么用
- 循环微生物特征可能作为ESRD患者心血管死亡风险的潜在生物标志物,但尚需进一步验证。
局限性
- 仅中位随访2.0年,长期关联不明确。
- 微生物特征与心血管死亡的关联为边缘显著,不能排除偶然性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Patients with end-stage renal disease (ESRD) experience disproportionately high cardiovascular morbidity and mortality. Accumulating evidence suggests a role for the circulating microbiome in the pathogenesis of cardiovascular disease; however, little is known about its association with premature cardiovascular mortality in ESRD. METHODS: In a pilot case-control study of 17 hemodialysis patients who died of a cardiovascular event and 17 matched hemodialysis controls who remained alive during a median follow-up of 2.0 years, we compared the levels and composition of circulating microbiome, including Bacteria, Archaea, and Fungi, in serum samples by quantitative polymerase chain reaction and 16S or Internal Transcribed Spacer (ITS) ribosomal RNA (rRNA) sequencing, respectively. Associations of the circulating cell-free microbial signatures with clinical parameters and cardiovascular death were examined using the Spearman rank correlation and multivariable conditional logistic regression, respectively. RESULTS: Both 16S and ITS rRNA were detectable in all (except 3 for ITS) examined patients' serum samples. Despite no significant difference in 16S rRNA levels and α diversity between cases and controls, taxonomic analysis demonstrated differential community membership between groups, with significantly greater Actinobacteria and less Proteobacteria observed in cases than in controls at the phylum level. Proportions of Actinobacteria and Proteobacteria phyla were significantly correlated with plasma nuclear factor erythroid 2-related factor 2 (Nrf2) levels (rho = -0.41 and 0.42, P = 0.015 and 0.013, respectively) and marginally associated with risk of cardiovascular death (adjusted odds ratios [95% confidence intervals] = 1.12 [0.98-1.29] and 0.88 [0.76-1.02] for 1% increase, respectively). CONCLUSION: Alterations of the circulating cell-free microbial signatures may be associated with higher premature cardiovascular mortality in ESRD.
引用
- Sumida K, Pierre JF, Han Z, et al. Circulating Microbial Signatures and Cardiovascular Death in Patients With ESRD. Kidney Int Rep. 2021. PMID: 34622101. doi:10.1016/j.ekir.2021.07.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。